202 related articles for article (PubMed ID: 4550120)
1. Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosis.
Salen G; Polito A
J Clin Invest; 1972 Jan; 51(1):134-40. PubMed ID: 4550120
[TBL] [Abstract][Full Text] [Related]
2. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Tint GS
Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
Salen G; Grundy SM
J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999
[TBL] [Abstract][Full Text] [Related]
4. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
Björkhem I; Buchmann MS; Skrede S
Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
[TBL] [Abstract][Full Text] [Related]
5. Transformation of 5 alpha-cholest-7-en-3 beta-ol to cholesterol and cholestanol in cerebrotendinous xanthomatosis.
Tint GS; Salen G
J Lipid Res; 1974 May; 15(3):256-62. PubMed ID: 4827915
[TBL] [Abstract][Full Text] [Related]
6. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O
J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058
[TBL] [Abstract][Full Text] [Related]
7. A novel route for the biosynthesis of cholestanol, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.
Skrede S; Bjørkhem I
Scand J Clin Lab Invest Suppl; 1985; 177():15-21. PubMed ID: 3865344
[TBL] [Abstract][Full Text] [Related]
8. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism.
Salen G
Ann Intern Med; 1971 Dec; 75(6):843-51. PubMed ID: 5134895
[No Abstract] [Full Text] [Related]
9. On the mechanism of biosynthesis of cholestanol from 7 alpha-hydroxycholesterol.
Buchmann MS; Björkhem I; Lund AM; Skrede S
Scand J Clin Lab Invest Suppl; 1986; 184():41-6. PubMed ID: 3109015
[TBL] [Abstract][Full Text] [Related]
10. High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis.
Kuriyama M; Fujiyama J; Kasama T; Osame M
J Lipid Res; 1991 Feb; 32(2):223-9. PubMed ID: 2066659
[TBL] [Abstract][Full Text] [Related]
11. Sterol synthesis in the human arterial intima.
Chorbanian AV
J Clin Invest; 1968 Mar; 47(3):595-603. PubMed ID: 5637146
[TBL] [Abstract][Full Text] [Related]
12. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
Clarenbach JJ; Lindenthal B; Dotti MT; Federico A; Kelleher JK; von Bergmann K
Metabolism; 2005 Mar; 54(3):335-44. PubMed ID: 15736111
[TBL] [Abstract][Full Text] [Related]
13. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S
N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810
[TBL] [Abstract][Full Text] [Related]
14. A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens.
McKenna P; Morgan SJ; Bosanquet RC; Laker MF
Br J Ophthalmol; 1990 Oct; 74(10):629-30. PubMed ID: 2285688
[TBL] [Abstract][Full Text] [Related]
15. Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases.
Canelas HM; Quintão EC; Scaff M; Vasconcelos KS; Brotto MW
Acta Neurol Scand; 1983 May; 67(5):305-11. PubMed ID: 6410671
[TBL] [Abstract][Full Text] [Related]
16. Plasma esterification of cholestanol, normally and in cerebrotendinous xanthomatosis.
Skrede S; Stokke KT
Scand J Clin Lab Invest; 1974 Apr; 33(2):97-100. PubMed ID: 4853665
[No Abstract] [Full Text] [Related]
17. Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid.
Björkhem I; Skrede S; Buchmann MS; East C; Grundy S
Hepatology; 1987; 7(2):266-71. PubMed ID: 3557306
[TBL] [Abstract][Full Text] [Related]
18. Studies of the mechanism of the increased biosynthesis of cholestanol in cerebrotendinous xanthomatosis. The activity of delta 5-3 beta-hydroxysteroid dehydrogenase.
Buchmann MS; Björkhem I; Fausa O; Skrede S
Scand J Gastroenterol; 1985 Dec; 20(10):1262-6. PubMed ID: 3868019
[TBL] [Abstract][Full Text] [Related]
19. Cerebrotendinous xanthomatosis: in vivo labeling of cerebral sterols and sterol esters.
Gardner-Medwin D; Kishimoto Y; Derby BM; Moser HW
Trans Am Neurol Assoc; 1971; 96():241-4. PubMed ID: 5159092
[No Abstract] [Full Text] [Related]
20. Subcellular distribution of cerebral cholestanol in cerebrotendinous xanthomatosis.
Stahl WL; Sumi SM; Swanson PD
J Neurochem; 1971 Mar; 18(3):403-13. PubMed ID: 5559251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
